AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
10min chapter
Introducing The Journal: Trillion Dollar Shot
Science Vs
The Journey of Developing Ozempic: Overcoming Challenges in GLP-1 Research
Explore the early stages of developing a new class of drugs based on GLP-1 hormone to treat diabetes, as recounted by lead researcher Lada Knudsen and her team at Novo Nordisk. Despite facing skepticism, resource limitations, and safety concerns during clinical trials, the team's perseverance and dedication eventually led to the successful development and approval of Ozempic after more than a decade of hard work.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode